Health Canada’s regulatory response to COVID-19: International engagement (English, HTML)

View metadata and access the original English HTML file: Health Canada’s regulatory response to COVID-19: International engagement.

Format

HTML

Access

file-only

Publisher-reported update

2022-06-07

During the COVID-19 pandemic, Health Canada is working closely with domestic and international partners to anticipate and meet Canadians' health product needs. This involves discussing, collaborating and leveraging resources on issues related to clinical trials and investigational testing, drug and medical device market authorizations, health product risk assessments, and potential drug and medical device shortages.

Access original file